Literature DB >> 19809561

Nationwide cancer incidence in Korea, 2003-2005.

Young-Joo Won1, Joohon Sung, Kyu-Won Jung, Hyun-Joo Kong, Sohee Park, Hai-Rim Shin, Eun-Cheol Park, Yoon-Ok Ahn, In Kyoung Hwang, Duk-Hee Lee, Jin-Su Choi, Woo-Cheol Kim, Tae-Yong Lee, Cheol-In Yoo, Jong-Myon Bae, Ok-Nam Kim, Woojin Chung, In-Sik Kong, Duk-Hyoung Lee, Jin-Soo Lee.   

Abstract

PURPOSE: To estimate the current cancer burden in Korea, newly diagnosed cancer cases and cancer incidence rates were calculated for the years 2003~2005.
MATERIALS AND METHODS: The cancer incidence cases and rates were calculated from the Korea National Cancer Incidence Database. Crude and age-standardized incidence rates were calculated by gender for specified cancer sites in 5-year age groups.
RESULTS: From 2003 to 2005, 398,824 cases of cancer were newly diagnosed in Korea (218,856 in men and 179,968 in women). For all sites combined, the crude incidence rate (CR) was 300.0 and 248.2 for men and women and the age-standardized incidence rate (ASR) was 297.0 and 191.2 per 100,000, respectively. Among men, five leading cancers were stomach (CR 66.0, ASR 64.2), lung (CR 48.5, ASR 50.3), liver (CR 44.9, ASR 42.1), colon and rectum (CR 37.9, ASR 37.2), and prostate cancer (CR 12.7, ASR 13.8). Among women, five leading cancers were breast (CR 37.3, ASR 29.0), thyroid (CR 36.2, ASR 28.8), stomach (CR 34.1, ASR 25.4), colon and rectum (CR 28.0, ASR 21.1), and lung cancer (CR 17.9, ASR 12.8). In the 0~14-year-old group, leukemia was the most common in both sexes; in the 15~34 group, the most common cancer was stomach cancer for men and thyroid cancer for women; in the 35~64 group, stomach cancer for men and breast cancer for women; among those 65 and over, lung cancer for men and stomach cancer, for women, respectively.
CONCLUSION: The cancer incidence rates have increased in recent years, and more cancers are expected to develop as Korea is quickly becoming an aged society. The cancer incidence statistics in this report can be used as an important source to effectively plan and evaluate the cancer control program in Korea.

Entities:  

Keywords:  Cancer incidence; Korea; Nationwide cancer registry

Year:  2009        PMID: 19809561      PMCID: PMC2757659          DOI: 10.4143/crt.2009.41.3.122

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  6 in total

1.  International rules for multiple primary cancers (ICD-0 third edition).

Authors: 
Journal:  Eur J Cancer Prev       Date:  2005-08       Impact factor: 2.497

2.  [Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index].

Authors:  W Ajiki; H Tsukuma; A Oshima
Journal:  Nihon Koshu Eisei Zasshi       Date:  1998-10

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

4.  Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database.

Authors:  Hai-Rim Shin; Young-Joo Won; Kyu-Won Jung; Hyun-Joo Kong; Seon-Hee Yim; Jung-Kyu Lee; Hong-In Noh; Jong-Koo Lee; Paola Pisani; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

Review 5.  Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.

Authors:  D Max Parkin; Freddie Bray
Journal:  Eur J Cancer       Date:  2009-01-06       Impact factor: 9.162

6.  National cancer incidence for the year 2002 in Korea.

Authors:  Hai-Rim Shin; Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Seon-Hee Yim; Joohon Sung; Sun-Won Seo; Ki-Young Kim; Sang-Yi Lee; In-Sik Kong; In Kyoung Hwang; Choong Won Lee; Ze-Hong Woo; Tae-Yong Lee; Jin-Su Choi; Cheol-In Yoo; Jong-Myon Bae; Keun-Young Yoo
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679

  6 in total
  51 in total

1.  Population-based survival data for brain tumors in Korea.

Authors:  Kyu-Won Jung; Heon Yoo; Hyun-Joo Kong; Young-Joo Won; Sohee Park; Seung Hoon Lee
Journal:  J Neurooncol       Date:  2012-06-04       Impact factor: 4.130

2.  Gastric cancer screening in Korea: report on the national cancer screening program in 2008.

Authors:  Kyung Sook Lee; Dong Kwan Oh; Mi Ah Han; Hoo-Yeon Lee; Jae Kwan Jun; Kui Son Choi; Eun-Cheol Park
Journal:  Cancer Res Treat       Date:  2011-06-30       Impact factor: 4.679

3.  Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.

Authors:  Jina Yun; Kyoung-Mee Kim; Seung Tae Kim; Jung-Hoon Kim; Jung A Kim; Jee Hyun Kong; Soo Hyeon Lee; Young-Woong Won; Jong-Mu Sun; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

4.  Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness.

Authors:  Sung Yong Oh; Chi Young Jeong; Soon Chan Hong; Tae Hyo Kim; Chang Yoon Ha; Hyun Jin Kim; Gyeong-Won Lee; In Gyu Hwang; Joung Soon Jang; Hyuk-Chan Kwon; Jung Hun Kang
Journal:  Invest New Drugs       Date:  2010-04-01       Impact factor: 3.850

5.  Comparison of continence recovery between robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy: a single surgeon experience.

Authors:  Seung Jun Son; Sang Chul Lee; Chang Wook Jeong; Seong Jin Jeong; Seok Soo Byun; Sang Eun Lee
Journal:  Korean J Urol       Date:  2013-09-10

6.  Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea.

Authors:  Hai-Rim Shin; Jin-Kyoung Oh; Min Kyung Lim; Aesun Shin; Hyun-Joo Kong; Kyu-Won Jung; Young-Joo Won; Sohee Park; Sang-Jae Park; Sung-Tae Hong
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

7.  Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Authors:  Kyung A Kwon; Sung Hyun Kim; Sung Yong Oh; Suee Lee; Jin-Yeong Han; Kyeong Hee Kim; Ri Young Goh; Hong Jo Choi; Ki Jae Park; Mee Sook Roh; Hyo-Jin Kim; Hyuk-Chan Kwon; Jong Hoon Lee
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

8.  Cancer statistics in Korea: incidence, mortality and survival in 2006-2007.

Authors:  Kyu-Won Jung; Sohee Park; Hyun-Joo Kong; Young-Joo Won; You-Kyung Boo; Hai-Rim Shin; Eun-Cheol Park; Jin-Soo Lee
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

9.  Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients.

Authors:  Hyuk-Chan Kwon; Sung-Hyun Kim; Sung Yong Oh; Suee Lee; Ji Hyun Lee; Jin Seok Jang; Min Chan Kim; Ki Han Kim; Su-Jin Kim; Seong-Geun Kim; Hyo-Jin Kim
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

10.  Cancer statistics in Korea: incidence, mortality and survival in 2005.

Authors:  Kyu-Won Jung; Young-Joo Won; Sohee Park; Hyun-Joo Kong; Joohon Sung; Hai-Rim Shin; Eun-Cheol Park; Jin Soo Lee
Journal:  J Korean Med Sci       Date:  2009-11-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.